11-63681666-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_001265589.2(RTN3):c.30C>T(p.Ser10Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00953 in 1,611,502 control chromosomes in the GnomAD database, including 101 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0077 ( 9 hom., cov: 32)
Exomes 𝑓: 0.0097 ( 92 hom. )
Consequence
RTN3
NM_001265589.2 synonymous
NM_001265589.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.269
Genes affected
RTN3 (HGNC:10469): (reticulon 3) This gene belongs to the reticulon family of highly conserved genes that are preferentially expressed in neuroendocrine tissues. This family of proteins interact with, and modulate the activity of beta-amyloid converting enzyme 1 (BACE1), and the production of amyloid-beta. An increase in the expression of any reticulon protein substantially reduces the production of amyloid-beta, suggesting that reticulon proteins are negative modulators of BACE1 in cells. Alternatively spliced transcript variants encoding different isoforms have been found for this gene, and pseudogenes of this gene are located on chromosomes 4 and 12. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 11-63681666-C-T is Benign according to our data. Variant chr11-63681666-C-T is described in ClinVar as [Benign]. Clinvar id is 777228.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.269 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00775 AC: 1180AN: 152270Hom.: 9 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1180
AN:
152270
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00786 AC: 1950AN: 247996 AF XY: 0.00785 show subpopulations
GnomAD2 exomes
AF:
AC:
1950
AN:
247996
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00972 AC: 14176AN: 1459114Hom.: 92 Cov.: 31 AF XY: 0.00946 AC XY: 6863AN XY: 725696 show subpopulations
GnomAD4 exome
AF:
AC:
14176
AN:
1459114
Hom.:
Cov.:
31
AF XY:
AC XY:
6863
AN XY:
725696
Gnomad4 AFR exome
AF:
AC:
46
AN:
33326
Gnomad4 AMR exome
AF:
AC:
247
AN:
44382
Gnomad4 ASJ exome
AF:
AC:
592
AN:
26036
Gnomad4 EAS exome
AF:
AC:
0
AN:
39536
Gnomad4 SAS exome
AF:
AC:
58
AN:
86038
Gnomad4 FIN exome
AF:
AC:
333
AN:
53182
Gnomad4 NFE exome
AF:
AC:
12345
AN:
1110598
Gnomad4 Remaining exome
AF:
AC:
543
AN:
60274
Heterozygous variant carriers
0
683
1366
2049
2732
3415
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
444
888
1332
1776
2220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00774 AC: 1179AN: 152388Hom.: 9 Cov.: 32 AF XY: 0.00696 AC XY: 519AN XY: 74530 show subpopulations
GnomAD4 genome
AF:
AC:
1179
AN:
152388
Hom.:
Cov.:
32
AF XY:
AC XY:
519
AN XY:
74530
Gnomad4 AFR
AF:
AC:
0.00223558
AN:
0.00223558
Gnomad4 AMR
AF:
AC:
0.00849118
AN:
0.00849118
Gnomad4 ASJ
AF:
AC:
0.0230415
AN:
0.0230415
Gnomad4 EAS
AF:
AC:
0.000192604
AN:
0.000192604
Gnomad4 SAS
AF:
AC:
0.000413907
AN:
0.000413907
Gnomad4 FIN
AF:
AC:
0.00507996
AN:
0.00507996
Gnomad4 NFE
AF:
AC:
0.0117007
AN:
0.0117007
Gnomad4 OTH
AF:
AC:
0.00992439
AN:
0.00992439
Heterozygous variant carriers
0
72
144
216
288
360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 11, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at